| 영문 | peripheral nerve | 한글 | 말초신경 |
|---|---|---|---|
| 설명 | 중추신경계를 제외한 나머지 모든신경을 말함. 중추신경계는 뇌와 척수를 말하며, 그외 나머지 신경들로써 실제적으로 각 기관이나 사지 말단에 신경이 분포하며, 자극을 전달하는 일을 하는 신경을 모두 통틀어 말초신경이라 한다. 뇌에서 바로 나와 분포하는 뇌신경과 척수에서 기시하는 척수신경도 모두 말초신경에 해당한다. 또한 말초신경에는 각종 자율신경을 담당하는 교감신경, 부교감신경도 포함된다. |
||
| 영문 | staging of tumors | 한글 | 종양의 병기 |
|---|---|---|---|
| 설명 | 병기는 종양의 파급정도 및 위험성을 일정한 기준에 의해 표시하는 방법으로서 임상적, 외과적, 병리학적인 방법에 의해 실시하여 평가한다. 병기의 구체적 목적은 치료의 계획을 세우는데 도움이 되고, 예후에 대한 지침을 제시하는 데 있다. 또한, 치료의 결과를 평가하는데 도움이 되어서, 치료후 서로 정보교환을 용이하게 하여 보다 나은 치료계획수립에 중요하다. 1)해부학적 병기(anatomic stage): 일반적으로 TMN분류를 사용한다. 질병의 침범 범위를 세 부분으로 표시함. T항목: 종양의 일차성 침범 범위를 표시하며 흔히 종양의 크기, 침범의 깊이, 표면 전파 등의 세 가지 형태에 기초를 둠. N항목: 종양의 이차성 또는 림프절 침범 범위를 표시하며 림프절의 크기, 경도, 숫자 등에 기초를 둠. M항목: 종양의 전이, 즉 혈관성 침범 범위를 표시하며 일반적으로 중요한 것은 전이의 정도가 아니라 전이의 유무임. 2) 조직학적 분류: 현미경적 소견에 의해 암세포의 악성 정도를 표시하며 특히 연조직육종의 예후에 중요함. 또 난소, 고환 종양 등은 병리조직학적 분류에 따라 치료방법이 다르며 호지킨병과 비호지킨림프종의 구분에도 중요함. |
||
| PerNET | peripheral neuroectodermal tumor |
|---|---|
| PNET | peripheral neuroepithelioma; primitive neuroectodermal tumor |
| PV | pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc... |
| NET | nasoendotracheal tube; nerve excitability test; neuroectodermal tumor; neuroendocrine tumor; norepin... |
| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
| PNET | Peripheral neuroectodermal tumors |
|---|---|
| PPNET | Peripheral primitive neuroectodermal tumor |
| MNTI | Melanotic neuroectodermal tumor of infancy |
| PNET | Primitive Neuroectodermal Tumor |
| EPT | Endocrine pancreatic tumors |
| neuroectodermal tumour, peripheral | A heterogeneous group of malignant neoplasms arising in either supportive structures or neuronal tissue. They occur in adolescents and young adults. This tumour shares a number of characteristics with ewing's sarcoma: it is highly cellular and consists of a monotonous pattern of primitive-appearing round cells. The chest wall is the most common site but the trunk, abdomen, and pelvis are other primary sites. (12 Dec 1998) |
|---|---|
| melanotic neuroectodermal tumour of infancy | A benign neoplasm of neuroectodermal origin that most often involves the anterior maxilla of infants in the first year of life. It presents clinically as a rapidly growing blue-black lesion producing a destructive radiolucency; histologically, it is characterised by small round undifferentiated tumour cells interspersed with larger polyhedral melanin-producing cells arranged in an alveolar configuration. Synonym: melanoameloblastoma, pigmented ameloblastoma, pigmented epulis, progonoma of jaw, retinal anlage tumour. (05 Mar 2000) |
| primitive neuroectodermal tumour | A designation used to refer to a group of morphologically similar embryonal neoplasms that arise in intracranial and peripheral sites of the nervous system and which may show various degrees of cellular differentiation; includes medulloblastoma, pineoblastoma, etc. (05 Mar 2000) |
| primitive neuroectodermal tumours | A type of brain tumour. Prenatal diagnosis: diagnosis before birth. Methods for prenatal diagnosis include ultrasound (of the uterus, placenta and developing foetus), chorionic villus sampling to obtain tissue for chromosome or biochemical analysis, amniocentesis to obtain amniotic fluid for the analysis of chromosmes, enzymes, DNA, etc. A growing number of birth defects and diseases are now amenable to prenatal diagnosis. Also called antenatal diagnosis. (12 Dec 1998) |
| neuroectodermal | Relating to the neuroectoderm. (05 Mar 2000) |
| neuroectodermal junction | The margin of the embryonic neural plate separating it from the embryonic ectoderm; cells from this region form the neural crest. Synonym: neurosomatic junction. (05 Mar 2000) |
| neuroectodermal tumour, melanotic | A benign, rapidly growing, deeply pigmented tumour of the jaw and occasionally of other sites, consisting of an infiltrating mass of cells arranged in an alveolar pattern, and occurring almost exclusively in infants. Its source of origin is in dispute, the various theories giving rise to its several names. (12 Dec 1998) |
| neuroectodermal tumour, primitive | A malignant brain tumour sharing common features and biologic properties with medulloblastoma. Some pathologists and clinicians use the terms interchangeably: they both can disseminate throughout the nervous system and, in some cases, systemically. most lesions arise from the posterior fossa in children under five years of age. The tumour often produces hydrocephalus and symptoms of increased intracranial pressure. Papilledema is often present. (12 Dec 1998) |
| neuroectodermal tumours | Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells. (12 Dec 1998) |
| catheterization, peripheral | Insertion of a catheter into a peripheral artery, vein, or airway for diagnostic or therapeutic purposes. (12 Dec 1998) |
| peripheral | <anatomy> Pertaining to or situated at or near the periphery, situated away from a centre or central structure. (18 Nov 1997) |
| peripheral aneurysm | A saclike aneurysm springing from one side of an artery, an aneurysm of one of the smaller branches of an artery. (05 Mar 2000) |
| peripheral anterior synechia | Adhesion of the iris to the posterior surface of the cornea in the angle of the anterior chamber; associated with angle-closure glaucoma. Synonym: peripheral anterior synechia. Origin: G. Gonia, angle, + synechis, holding together (05 Mar 2000) |
| peripheral arteriosclerosis | Arteriosclerosis in any of the vessels beyond the aorta; most often refers to the lower extremities. (05 Mar 2000) |
| peripheral blood stem cell transplantation | A procedure that is similar to bone marrow transplantation. Doctors remove healthy immature cells (stem cells) from a patient's blood and store them before the patient receives high-dose chemotherapy and possibly radiation therapy to destroy the leukaemia cells. The stem cells are then returned to the patient, where they can produce new blood cells to replace cells destroyed by the treatment. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|